---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-001541"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:44:33.608169+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience sets Jan 14, 2025 annual/special meeting; director nomination deadline Nov 25

## Summary
- Joint Annual and Special Meeting scheduled for January 14, 2025.
- Stockholder approval required for Private Placement Warrants issued in October 2024.
- Director nominee submissions due by noon ET on November 25, 2024, to Vanessa Carle.
- Submission address: vcarle@lexariabioscience.com; Schedule 14N required.

## SEC filing metadata
- accession: 0001640334-24-001541
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033424001541/0001640334-24-001541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033424001541/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-001541
- JSON: https://secwatch.observer/filing/0001640334-24-001541.json
- Plain text: https://secwatch.observer/filing/0001640334-24-001541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.